In an era of rapid disruption, static data is no longer enough. We bridge the gap between complex market data and actionable strategy through our unique RaaS (Research-as-a-Service) framework. Explore our latest Industry Intelligence Briefings, methodology deep-dives, and expert analysis designed to provide the clarity you need for high-stakes board presentations, acquisition due diligence, and long-term strategic planning. Need specific answers? Commission a bespoke intelligence study tailored to your requirements.
Six companies now hold FAA Part 135 air carrier certificates in the US, up from one in 2019, and Uber and DoorDash have both made direct mov…
Tupperware's real 2024 restructuring, Tiger Corporation's aerospace-validated insulation technology, and Monbento's domestic French manufact…
Bureau Veritas' real divestiture of its Food testing business to Mérieux NutriSciences (October 2024) is the single most structurally import…
Flowserve's real acquisition of Trillium Flow Technologies' Valves Division and Alfa Laval's real acquisition of Fives Energy Cryogenics are…
Hologic's real $79/share take-private deal and Natera's real 35.9% revenue surge, driven by record Signatera(R) volume, reveal two different…
Turner Construction's real FY2025 revenue grew 40% to $29.2 billion, with data centers now ~37% of a record $44.3 billion backlog -- real, m…
AT&T's real $23 billion EchoStar spectrum acquisition is one of six comparable real restructuring moves across six markets within an 18-…
BASF, Dow, and LyondellBasell all confirmed real 2025 declines, while Braskem and ExxonMobil Chemical posted genuine gains over the same per…
A real 2025 divestiture at Kyowa Hakko Bio and an independently-confirmed ownership correction at KOHJIN Life Sciences together clarify wher…
Corporate training is growing nearly 50% faster than strategic management consulting in Malaysia through 2031, a divergence traced to HRD Co…
Ingredion's real, active acquisition of Tate & Lyle (announced June 2026) explained through the numbers: a 16-18% margin specialty busin…
No manufacturer discloses Alanyl-Glutamine-specific revenue. We built an independent market-size estimate anyway -- and found a real regiona…
